Mary Wilson
Well-known member
— Committee advises booster at least 2 months following initial Johnson & Johnson shot
October 15, 2021
by Molly Walker
Despite limited available data, an FDA advisory panel recommended a booster dose of Johnson & Johnson's COVID-19 vaccine for all individuals who received the single-dose vaccine, to be given at least 2 months after the initial dose.
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 19-0 that the booster dose at this interval was safe and effective for individuals ages 18 and up who received the Johnson & Johnson vaccine under emergency use authorization (EUA).
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/95080
October 15, 2021
by Molly Walker
Despite limited available data, an FDA advisory panel recommended a booster dose of Johnson & Johnson's COVID-19 vaccine for all individuals who received the single-dose vaccine, to be given at least 2 months after the initial dose.
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 19-0 that the booster dose at this interval was safe and effective for individuals ages 18 and up who received the Johnson & Johnson vaccine under emergency use authorization (EUA).
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/95080
